Shattuck Labs, Inc. Hits New 52-Week High of $5.19

Shattuck Labs, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 5.19 on March 5, 2026. This achievement marks a notable increase from its 52-week low of USD 0.69, reflecting a substantial upward movement in the stock's performance over the past year. Despite this recent high, Shattuck Labs has experienced a one-year performance decline of 23.88%, contrasting sharply with the S&P 500's gain of 18.89% during the same period. The company's market capitalization stands at USD 254 million, indicating its microcap status within the industry. Financial metrics reveal that Shattuck Labs is currently loss-making, with a return on equity of -58.79% and a debt-to-equity ratio of -0.91. The stock does not offer a dividend yield, and its price-to-book ratio is 2.72. As the company continues to navigate the competitive landscape of pharmaceuticals and biotechnology, this new price point may serve as a pivotal moment in its ongoing journey.